Dr. Alexis Patsias, MD

Dr. Patsias practices at Sharp Grossmont Outpatient Surgery Center in La Mesa, California.

Dr. Patsias' NPI, 1326452855, was assigned on June 12, 2014. Dr. Patsias graduated from University of San Martin de Porres Faculty of Medicine in 2010. Dr. Patsias holds California license A160436.

Dr. Patsias' primary practice is Sharp Grossmont Outpatient Surgery Center, at 5565 Grossmont Center Dr, La Mesa, CA 91942 in San Diego County. The practice phone is (619) 462-8620.

Dr. Patsias' primary practice is Sharp Grossmont Outpatient Surgery Center in La Mesa, California. Dr. Patsias is also affiliated with Sharp Grossmont Hospital. The medical group on file is Emergency and Acute Care Medical Corporation. Dmand AI also links Dr. Patsias to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Patsias practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Patsias' primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Patsias is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Patsias' licenses on file in 2 states: California and Oklahoma.

Dmand AI lists acute sinusitis, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, endoscopic sinus surgery, hearing loss and impairment, swimmer's ear and vertigo among the conditions Dr. Patsias treats.

CMS data shows 2,036 Medicare services from Dr. Patsias across 12 procedure codes in 2024, for 365 Medicare patients. Medicare paid $195,977 for them. Every service was in an office.

CMS counts 365 Medicare patients who saw Dr. Patsias in 2024. The largest group is 65 to 74, with 155 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 44% are also on Medicaid. Their average risk score is 1.36, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Patsias' median patient age at 65, with 61% women.

In 2024, Dr. Patsias wrote 2,722 Medicare Part D claims for 681 patients. 99% of them were for generic drugs. CMS names the drug for 2,610 of them, across 15 drugs with 11 or more claims each, at $51,628 in total drug cost. In 2023, CMS named 1,813 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Patsias for performance year 2024, reported as part of a group. Dr. Patsias accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Patsias, published from 2014 to 2015. 2015 was the busiest year, with 3. The most frequent topics are Carcinoma, Squamous Cell, Feasibility Studies and Head and Neck Neoplasms. Dr. Patsias has published most often in Head Neck. Dr. Patsias' most frequent co-authors are Eric M. Genden, MD, Andrew Gregory Sikora, MD, PhD and Sharmila Anandasabapathy, MD.

CMS Open Payments shows 177 general payments to Dr. Patsias from 21 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 53% of the total. Stryker Corporation paid the most, $4,615.

Dr. Patsias graduated from University of San Martin de Porres Faculty of Medicine in 2010.

Dr. Patsias is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.